Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

KYNBKYNTRA BIO, INC.

Nasdaq · CIK 0000921299
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts414

Identity from submissions API

NameKYNTRA BIO, INC.
CIK0000921299
TickersKYNB
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN770357827
LEI—
Fiscal year end1231
State of incorporation—
Phone415-978-1200
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • FIBROGEN INC (2002-08-14T04:00:00.000Z → 2026-01-07T05:00:00.000Z)
Business address
350 BAY STREET
SUITE 100 #6009
SAN FRANCISCO
CA
94133
CA
Mailing address
350 BAY STREET
SUITE 100 #6009
SAN FRANCISCO
CA
94133
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

1188 filing rows loaded from submissions recent; extra archives: CIK0000921299-submissions-001.json (185 filings, 2002-08-14 to 2016-02-22).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 4 xslF345X06/form4-11182026_121129.xml 0001815638-26-000013 5601
2026-11-16 10-Q 10-Q 0001193125-26-463519 001-36740 261560883 34 13676387 1 1
2026-11-16 8-K 8-K 2.02,9.01 0001193125-26-463442 001-36740 261560471 34 504531 1 1
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005240 005-88653 261558033 34 10582
2026-10-06 4 xslF345X06/form4-10062026_101058.xml 0001632720-26-000004 5583
2026-10-06 3 xslF345X06/form3-10062026_101006.xml 0001632720-26-000003 11380
2026-10-06 8-K 8-K 3.01 0001193125-26-415545 001-36740 261444036 34 150802 1 1
2026-10-01 8-K 8-K 5.02 0001193125-26-409819 001-36740 261428937 34 197054 1 1
2026-09-09 4 xslF345X06/form4-09102026_120924.xml 0001815638-26-000011 5678
2026-09-09 4 xslF345X06/form4-09102026_120933.xml 0002040705-26-000007 5028
2026-08-31 8-K 8-K 1.01,2.03,7.01,9.01 0001193125-26-377059 001-36740 261347612 34 212595 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003600 005-88653 261277236 34 10580
2026-08-13 10-Q 10-Q 0001193125-26-349183 001-36740 261273410 34 11494272 1 1
2026-08-13 8-K 8-K 2.02,9.01 0001193125-26-349141 001-36740 261273161 34 462303 1 1
2026-06-17 4 xslF345X06/form4-06172026_110643.xml 0001646395-26-000002 5564
2026-06-17 4 xslF345X06/form4-06172026_110619.xml 0001190642-26-000004 5530
2026-06-17 4 xslF345X06/form4-06172026_110646.xml 0001364719-26-000004 5589
2026-06-17 4 xslF345X06/form4-06172026_110615.xml 0001420987-26-000004 5569
2026-06-16 8-K 8-K 5.07 0001193125-26-271449 001-36740 261092467 34 152088 1 1
2026-06-09 4 xslF345X06/form4-06092026_090658.xml 0001815638-26-000009 5679
2026-06-09 4 xslF345X06/form4-06092026_090631.xml 0002040705-26-000005 5028
2026-06-09 8-K 8-K 8.01 0001193125-26-264000 001-36740 261076998 34 148064 1 1
2026-05-19 4/A xslF345X06/form4a-05192026_070512.xml 0001815638-26-000007 5837
2026-05-18 4 xslF345X06/form4-05182026_080501.xml 0001815638-26-000005 5449
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002165 005-88653 26984233 34 10576
2026-05-12 10-Q 10-Q 0001193125-26-219374 001-36740 26968442 34 10013561 1 1
2026-05-11 8-K 8-K 2.02,9.01 0001193125-26-216731 001-36740 26963122 34 377998 1 1
2026-04-27 ARS ARS 0001193125-26-182082 001-36740 26900950 34 686332
2026-04-27 DEFA14A DEFA14A 0001193125-26-182071 001-36740 26900927 34 3389382
2026-04-27 DEF 14A DEF 14A 0001193125-26-182044 001-36740 26900878 34 9378518 1 1
2026-04-09 8-K 8-K 3.01 0001193125-26-149624 001-36740 26851690 34 149072 1 1
2026-03-16 10-K 10-K 0001193125-26-108346 001-36740 26756786 34 21919278 1 1
2026-03-16 8-K 8-K 2.02,9.01 0001193125-26-108324 001-36740 26756643 34 484709 1 1
2026-03-10 4 xslF345X05/form4-03102026_090328.xml 0001815638-26-000003 5541
2026-03-10 4 xslF345X05/form4-03102026_090314.xml 0002040705-26-000003 4890
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001239 005-88653 26645084 34 10479
2026-02-05 4 xslF345X05/form4-02062026_020215.xml 0001815638-26-000002 5397
2026-02-05 4 xslF345X05/form4-02062026_020236.xml 0002040705-26-000002 5431
2026-01-07 8-K 8-K 5.03,8.01,9.01 0001193125-26-006327 001-36740 26515863 34 334183 1 1
2025-12-09 4 xslF345X05/form4-12092025_091258.xml 0002040705-25-000002 4824
2025-12-09 4 xslF345X05/form4-12092025_091206.xml 0001815638-25-000005 5474
2025-11-17 4 xslF345X05/form4-11172025_091148.xml 0001815638-25-000004 6718
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-005176 005-88653 251488776 34 10670
2025-11-10 10-Q 10-Q 0001193125-25-274241 001-36740 251466289 34 12698652 1 1
2025-11-10 8-K 8-K 2.02,9.01 0001193125-25-274192 001-36740 251466131 34 470815 1 1
2025-11-06 8-K 8-K 8.01 0001193125-25-269529 001-36740 251458399 34 148623 1 1
2025-09-09 4 xslF345X05/form4-09092025_110911.xml 0001415889-25-024014 6459
2025-09-09 4 xslF345X05/form4-09092025_110909.xml 0001415889-25-024012 7111
2025-09-05 8-K 8-K 2.01,9.01 0000921299-25-000007 001-36740 251297409 34 525238 1 1
2025-09-02 8-K 8-K 8.01,9.01 0000950170-25-112341 001-36740 251282997 34 182130 1 1
2025-08-18 8-K 8-K 8.01,9.01 0000950170-25-109571 001-36740 251226373 34 171101 1 1
2025-08-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003627 005-88653 251223526 34 10666
2025-08-14 8-K 8-K 1.01,9.01 0000950170-25-108280 001-36740 251213674 34 221388 1 1
2025-08-11 10-Q 10-Q 0000950170-25-106549 001-36740 251202088 34 11638850 1 1
2025-08-11 8-K 8-K 2.02,9.01 0000950170-25-106534 001-36740 251201955 34 467484 1 1
2025-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000725 005-88653 251158648 34 6177
2025-07-14 8-K 8-K 1.01,9.01 0000950170-25-095628 001-36740 251122381 34 224566 1 1
2025-07-02 4 xslF345X05/form4-07022025_080721.xml 0001415889-25-019067 5111
2025-06-13 8-K 8-K 1.02 0000950170-25-086142 001-36740 251046472 34 147486 1 1
2025-06-12 8-K 8-K 3.03,5.03,9.01 0000950170-25-085439 001-36740 251043113 34 272872 1 1
2025-06-09 8-K 8-K 1.01,5.02,5.07,9.01 0000950170-25-083676 001-36740 251033906 34 272190 1 1
2025-06-06 4 xslF345X05/form4-06062025_080642.xml 0001415889-25-015989 5520
2025-06-06 4 xslF345X05/form4-06062025_080655.xml 0001415889-25-015987 5486
2025-06-06 4 xslF345X05/form4-06062025_080651.xml 0001415889-25-015985 5525
2025-06-06 4 xslF345X05/form4-06062025_080643.xml 0001415889-25-015983 7900
2025-06-06 3 xslF345X02/form3-06062025_080638.xml 0001415889-25-015981 10111
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002255 005-88653 25951946 34 10679
2025-05-12 10-Q 10-Q 0000950170-25-069203 001-36740 25934899 34 11757530 1 1
2025-05-12 8-K 8-K 2.02,9.01 0000950170-25-069159 001-36740 25934696 34 393774 1 1
2025-04-25 ARS ARS 0000950170-25-058861 001-36740 25875201 34 3433384
2025-04-25 DEFA14A DEFA14A 0000950170-25-058852 001-36740 25875108 34 1607723
2025-04-25 DEF 14A DEF 14A 0000950170-25-058841 001-36740 25875043 34 14563817 1 1
2025-04-17 PRE 14A PRE 14A 0000950170-25-055539 001-36740 25848142 34 14090255 1 1
2025-04-04 8-K 8-K 5.03,9.01 0000950170-25-051219 001-36740 25815614 34 399950 1 1
2025-03-31 8-K 8-K 7.01 0000950170-25-046978 001-36740 25788088 34 223223 1 1
2025-03-28 8-K 8-K 1.01 0000950170-25-046948 001-36740 25787801 34 153438 1 1
2025-03-25 4 xslF345X05/form4-03252025_090301.xml 0001415889-25-008872 5640
2025-03-24 4 xslF345X05/form4-03242025_090301.xml 0001415889-25-008823 7516
2025-03-17 10-K 10-K 0000950170-25-040280 001-36740 25744623 34 20906153 1 1
2025-03-17 8-K 8-K 2.02,3.01,9.01 0000950170-25-040248 001-36740 25744499 34 476871 1 1
2025-03-07 4 xslF345X05/form4-03082025_120348.xml 0001415889-25-007459 8806
2025-03-07 4 xslF345X05/form4-03082025_120324.xml 0001415889-25-007457 8144
2025-03-07 4 xslF345X05/form4-03082025_120327.xml 0001415889-25-007455 4835
2025-02-24 8-K 8-K 1.01,9.01 0001193125-25-033539 001-36740 25658262 34 469236 1 1
2025-02-24 424B5 424B5 0001193125-25-033535 333-280597 25658224 33 605146
2025-02-20 8-K 8-K 1.01,2.02,5.02,7.01,9.01 0000950170-25-023729 001-36740 25643217 34 221702 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001311 005-88653 25631428 34 10668
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001085146-25-001357 005-88653 25622196 34 6781
2025-01-10 4 xslF345X05/form4-01102025_110123.xml 0001415889-25-001312 5377
2025-01-10 4 xslF345X05/form4-01102025_110107.xml 0001415889-25-001310 5345
2024-12-18 3 xslF345X02/form3-12182024_101212.xml 0001415889-24-029755 17189
2024-12-16 8-K 8-K 5.02 0000950170-24-136408 001-36740 241550276 34 240648 1 1
2024-12-09 4 xslF345X05/form4-12092024_081206.xml 0001415889-24-028744 6325
2024-12-09 4 xslF345X05/form4-12092024_081203.xml 0001415889-24-028743 5475
2024-12-09 4 xslF345X05/form4-12092024_081201.xml 0001415889-24-028742 4802
2024-11-14 SC 13G/A armistice-fgen093024a1.htm 0001172661-24-005295 005-88653 241463772 34 90699
2024-11-12 10-Q 10-Q 0000950170-24-125388 001-36740 241448185 34 11434228 1 1
2024-11-12 8-K 8-K 2.02,9.01 0000950170-24-125332 001-36740 241447926 34 404316 1 1
2024-11-12 SC 13G/A PRIMECAP MANAGEMENT CO/CA/ 0001085146-24-005550 005-88653 241447758 34 27576
2024-11-12 SC 13G/A UnitedStates_13G__FibroGenIn.txt 0000932471-24-000991 005-88653 241447031 34 6535
2024-11-04 SC 13G/A UnitedStates_13G__FibroGenIn.txt 0000932471-24-000491 005-88653 241422045 34 5614
2024-11-04 SC 13G/A UnitedStates_13G__FibroGenIn.txt 0000932471-24-000522 005-88653 241421829 34 5614
2024-10-03 8-K 8-K 1.02 0000950170-24-112331 001-36740 241351428 34 183250 1 1
2024-09-16 8-K 8-K 3.01 0000950170-24-106818 001-36740 241301081 34 148080 1 1
2024-09-13 8-K 8-K 5.02 0000950170-24-106359 001-36740 241297845 34 151625 1 1
2024-09-09 4 xslF345X05/form4-09092024_080907.xml 0001415889-24-023090 6273
2024-09-09 4 xslF345X05/form4-09092024_080904.xml 0001415889-24-023089 5425
2024-09-09 4 xslF345X05/form4-09092024_080901.xml 0001415889-24-023088 4753
2024-09-06 8-K 8-K 5.02 0000950170-24-104395 001-36740 241284603 34 148850 1 1
2024-08-07 S-8 S-8 0000950170-24-092973 333-281342 241184947 33 172706
2024-08-07 8-K 8-K 2.05 0000950170-24-092967 001-36740 241184896 34 149890 1 1
2024-08-06 10-Q 10-Q 0000950170-24-091808 001-36740 241179332 34 13692576 1 1
2024-08-06 8-K 8-K 2.02,9.01 0000950170-24-091766 001-36740 241179096 34 403497 1 1
2024-08-05 4 xslF345X05/form4-08052024_080844.xml 0001415889-24-020745 5426
2024-07-10 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-07-10 16:00:00 9999999995-24-002117 333-280597 241110962 33 1703
2024-07-09 CORRESP filename1.htm 0001193125-24-176845 47152
2024-07-09 UPLOAD filename1.pdf 0000000000-24-007721 333-280597 39978
2024-07-08 SC 13G/A us31572q8087_070824.txt 0001086364-24-008258 005-88653 241105240 34 12769
2024-06-28 S-3 S-3 0001193125-24-172413 333-280597 241086779 33 425053
2024-06-26 8-K 8-K 8.01,9.01 0000950170-24-077616 001-36740 241070648 34 19336693 1 1
2024-06-25 4 xslF345X05/form4-06252024_040601.xml 0001415889-24-018145 5424
2024-06-13 4 xslF345X05/form4-06132024_040604.xml 0001415889-24-016677 4525
2024-06-10 4 xslF345X05/form4-06102024_100611.xml 0001415889-24-016277 6274
2024-06-07 4 xslF345X05/form4-06072024_070604.xml 0001415889-24-016080 4753
2024-06-07 4 xslF345X05/form4-06072024_070602.xml 0001415889-24-016079 5425
2024-06-07 8-K 8-K 5.07,9.01 0000950170-24-070636 001-36740 241029516 34 441663 1 1
2024-06-06 4 xslF345X05/form4-06062024_080616.xml 0001415889-24-015859 5383
2024-06-06 4 xslF345X05/form4-06062024_080614.xml 0001415889-24-015858 5376
2024-06-06 4 xslF345X05/form4-06062024_080612.xml 0001415889-24-015857 5378
2024-06-06 4 xslF345X05/form4-06062024_080607.xml 0001415889-24-015855 5386
2024-06-06 4 xslF345X05/form4-06062024_080610.xml 0001415889-24-015856 5347
2024-06-06 4 xslF345X05/form4-06062024_080605.xml 0001415889-24-015854 5385
2024-06-06 4 xslF345X05/form4-06062024_080603.xml 0001415889-24-015853 5380
2024-05-06 10-Q 10-Q 0000950170-24-053554 001-36740 24917587 34 11134093 1 1
2024-05-06 8-K 8-K 2.02,9.01 0000950170-24-053533 001-36740 24917463 34 346052 1 1
2024-05-02 4 xslF345X05/form4-05022024_110520.xml 0001415889-24-012091 5425
2024-04-25 ARS ARS 0000950170-24-047879 001-36740 24872623 34 896625
2024-04-24 DEFA14A DEFA14A 0000950170-24-047707 001-36740 24871482 34 6025560
2024-04-24 DEF 14A DEF 14A 0000950170-24-047694 001-36740 24871393 34 7747469 1 1
2024-04-24 3 xslF345X02/form3-04242024_080453.xml 0001415889-24-011437 13505
2024-03-25 4 xslF345X05/form4-03252024_090320.xml 0001415889-24-009048 5423
2024-03-11 4 xslF345X05/form4-03112024_110334.xml 0001415889-24-007570 5198
2024-03-08 4 xslF345X05/form4-03092024_120351.xml 0001415889-24-007455 9593
2024-03-08 4 xslF345X05/form4-03092024_120313.xml 0001415889-24-007453 8745
2024-03-08 4 xslF345X05/form4-03092024_120348.xml 0001415889-24-007451 8082
2024-02-26 10-K 10-K 0000950170-24-020161 001-36740 24678824 34 22686915 1 1
2024-02-26 8-K 8-K 2.02,9.01 0000950170-24-020146 001-36740 24678736 34 407322 1 1
2024-02-23 4 xslF345X05/form4-02242024_010232.xml 0001415889-24-005156 7861
2024-02-23 4 xslF345X05/form4-02242024_010252.xml 0001415889-24-005154 7196
2024-02-23 4 xslF345X05/form4-02242024_010217.xml 0001415889-24-005152 7193
2024-02-14 SC 13G armistice-fgen123123.htm 0001172661-24-001352 005-88653 24636944 34 90604
2024-02-14 SC 13G/A FIBROGEN, INC. 0000902664-24-001633 005-88653 24633446 34 72310
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020921 005-88653 24628411 34 12970
2024-02-12 SC 13G/A PRIMECAP MANAGEMENT CO/CA/ 0001085146-24-001079 005-88653 24619748 34 27840
2024-02-05 4 xslF345X05/form4-02062024_010229.xml 0001415889-24-002750 5426
2024-01-26 SC 13G/A us31572q8087_012624.txt 0001086364-24-004636 005-88653 24568128 34 13312
2023-12-26 4 FORM 4 SUBMISSION 0001209191-23-059713 5478
2023-12-11 4 FORM 4 SUBMISSION 0001209191-23-058053 6299
2023-12-11 4 FORM 4 SUBMISSION 0001209191-23-058052 4734
2023-12-11 4 FORM 4 SUBMISSION 0001209191-23-058051 5397
2023-11-06 10-Q 10-Q 0000950170-23-059394 001-36740 231380082 34 14951310 1 1
2023-11-06 8-K 8-K 2.02,9.01 0000950170-23-059381 001-36740 231379977 34 499952 1 1
2023-11-03 4 FORM 4 SUBMISSION 0001209191-23-054320 5400
2023-10-27 8-K 8-K 3.01 0000950170-23-056018 001-36740 231355946 34 156939 1 1
2023-10-06 8-K 8-K 5.02 0000950170-23-052242 001-36740 231312429 34 160493 1 1
2023-09-25 4 FORM 4 SUBMISSION 0001209191-23-050526 5406
2023-09-08 4 FORM 4 SUBMISSION 0001209191-23-048820 6299
2023-09-08 4 FORM 4 SUBMISSION 0001209191-23-048815 9532
2023-09-08 4 FORM 4 SUBMISSION 0001209191-23-048809 4732
2023-09-08 4 FORM 4 SUBMISSION 0001209191-23-048808 4735
2023-09-06 4 FORM 4 SUBMISSION 0001209191-23-048555 8856
2023-09-06 4 FORM 4 SUBMISSION 0001209191-23-048554 9100
2023-09-06 8-K 8-K 5.02,9.01 0000950170-23-046574 001-36740 231237943 34 290083 1 1
2023-09-01 4 FORM 4 SUBMISSION 0001209191-23-048030 11279
2023-09-01 4 FORM 4 SUBMISSION 0001209191-23-048029 11289
2023-09-01 144 xsl144X01/primary_doc.xml 0001958244-23-001742 001-36740 231233508 33 7438
2023-08-29 8-K 8-K 8.01 0000950170-23-045111 001-36740 231223034 34 311139 1 1
2023-08-14 4 FORM 4 SUBMISSION 0001209191-23-045673 5096
2023-08-09 4 FORM 4 SUBMISSION 0001209191-23-045215 7315
2023-08-08 4 FORM 4 SUBMISSION 0001209191-23-045087 4981
2023-08-07 S-8 S-8 0000950170-23-039101 333-273765 231147926 33 232269
2023-08-07 10-Q 10-Q 0000950170-23-039070 001-36740 231147729 34 21679839 1 1
2023-08-07 8-K 8-K 2.02,9.01 0000950170-23-039052 001-36740 231147613 34 556329 1 1
2023-08-04 144 xsl144X01/primary_doc.xml 0001958244-23-001701 001-36740 231144604 33 7376
2023-07-25 8-K 8-K 5.02,8.01,9.01 0000950170-23-034234 001-36740 231106583 34 419272 1 1
2023-07-19 SC 13G FGEN_SC13G.htm 0001273087-23-000124 005-88653 231097201 34 81957
2023-07-19 8-K 8-K 2.05 0000950170-23-033458 001-36740 231095551 34 167839 1 1
2023-07-13 4 FORM 4 SUBMISSION 0001209191-23-042247 4960
2023-07-11 144 xsl144X01/primary_doc.xml 0001958244-23-001286 001-36740 231082564 33 5908
2023-07-10 4 FORM 4 SUBMISSION 0001209191-23-041969 5437
2023-06-26 4 FORM 4 SUBMISSION 0001209191-23-039700 4773
2023-06-26 8-K 8-K 8.01,9.01 0000950170-23-029736 001-36740 231039571 34 323913 1 1
2023-06-23 144 xsl144X01/primary_doc.xml 0001815638-23-000002 001-36740 231039309 33 5827
2023-06-22 4/A FORM 4/A SUBMISSION 0001209191-23-039157 6768
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037604 8881
2023-06-13 144 xsl144X01/primary_doc.xml 0001958244-23-000865 001-36740 231012460 33 5149
2023-06-09 144 xsl144X01/primary_doc.xml 0001950047-23-001474 001-36740 231006871 33 4544
2023-06-09 144 xsl144X01/primary_doc.xml 0001950047-23-001473 001-36740 231006863 33 4540
2023-06-09 144 xsl144X01/primary_doc.xml 0001950047-23-001471 001-36740 231006855 33 4508
2023-06-09 144 xsl144X01/primary_doc.xml 0001950047-23-001470 001-36740 231006850 33 4550
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-036081 11348
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-036080 11347
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-036079 11342
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-036078 11341
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-036077 7881
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-036076 11309
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-036074 11330
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-036073 9522
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-036066 6519
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-036065 6337
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-036064 7911
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-036054 4770
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-036051 7186
2023-06-09 8-K 8-K 5.07 0000950170-23-027252 001-36740 231005242 34 167792 1 1
2023-06-08 144 xsl144X01/primary_doc.xml 0001879223-23-000001 001-36740 231003505 33 7029
2023-06-08 144 xsl144X01/primary_doc.xml 0001958244-23-000853 001-36740 231003180 33 5141
2023-06-08 144 xsl144X01/primary_doc.xml 0001958244-23-000852 001-36740 231003179 33 5134
2023-06-07 144 xsl144X01/primary_doc.xml 0001775295-23-000004 001-36740 231000542 33 6428
2023-06-07 144 xsl144X01/primary_doc.xml 0001775295-23-000003 001-36740 231000529 33 7566
2023-06-07 144 xsl144X01/primary_doc.xml 0001775295-23-000002 001-36740 231000517 33 7033
2023-06-07 144 xsl144X01/primary_doc.xml 0001775295-23-000001 001-36740 231000509 33 9388
2023-06-07 144 xsl144X01/primary_doc.xml 0001949846-23-000127 001-36740 23998034 33 4256
2023-06-07 8-K 8-K 8.01,9.01 0000950170-23-026748 001-36740 23997788 34 375211 1 1
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034288 4768
2023-06-02 144 xsl144X01/primary_doc.xml 0001834161-23-000003 001-36740 23991010 33 7029
2023-05-31 DEFA14A DEFA14A 0000950170-23-025097 001-36740 23979113 34 970752
2023-05-18 8-K 8-K 8.01,9.01 0000950170-23-022879 001-36740 23933708 34 383397 1 1
2023-05-08 10-Q 10-Q 0000950170-23-018814 001-36740 23897861 34 13182275 1 1
2023-05-08 8-K 8-K 2.02,9.01 0000950170-23-018795 001-36740 23897745 34 454383 1 1
2023-05-01 8-K 8-K 1.01,2.03 0000950170-23-016300 001-36740 23874554 34 174494 1 1
2023-04-27 ARS ARS 0000950170-23-015287 001-36740 23857199 34 1047168
2023-04-27 DEFA14A DEFA14A 0000950170-23-015272 001-36740 23856935 34 241914
2023-04-27 DEF 14A DEF 14A 0000950170-23-015259 001-36740 23856818 34 7334485 1 1
2023-04-11 4 FORM 4 SUBMISSION 0001209191-23-024026 5437
2023-04-06 4 FORM 4 SUBMISSION 0001209191-23-023592 4765
2023-04-06 4 FORM 4 SUBMISSION 0001209191-23-023591 4773
2023-03-29 4 FORM 4 SUBMISSION 0001209191-23-021539 6348
2023-03-24 4 FORM 4 SUBMISSION 0001209191-23-021138 4770
2023-03-23 4/A FORM 4/A SUBMISSION 0001209191-23-020781 4898
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-018065 11655
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-018064 12125
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-018063 11648
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-018062 13214
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-018061 11454
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016362 4731
2023-02-27 424B5 424B5 0001193125-23-050860 333-266663 23675739 33 61322
2023-02-27 10-K 10-K 0000950170-23-004668 001-36740 23675409 34 30593745 1 1
2023-02-27 8-K 8-K 2.02,9.01 0000950170-23-004644 001-36740 23674770 34 555294 1 1
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012430 7242
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012428 7238
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012426 7242
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012425 7234
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012423 7911
2023-02-17 5/A FORM 5/A SUBMISSION 0001209191-23-010803 6195
2023-02-14 SC 13G/A SCHEDULE 13G/A, AMENDMENT #1 0000899140-23-000401 005-88653 23629848 34 50232
2023-02-09 SC 13G/A PRIMECAP MANAGEMENT CO/CA/ 0001085146-23-000904 005-88653 23606116 34 27757
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015946 005-88653 23603188 34 12892
2023-02-08 SC 13G/A AMENDED SCHEDULE 13G 0001445546-23-001076 005-88653 23597446 34 16353
2023-02-06 SC 13G/A us31572q8087_020623.txt 0001306550-23-007867 005-88653 23589512 34 13322
2023-02-02 5 FORM 5 SUBMISSION 0001209191-23-006278 4596
2023-01-10 4 FORM 4 SUBMISSION 0001209191-23-002803 5584
2023-01-04 4/A FORM 4/A SUBMISSION 0001209191-23-001354 4989
2023-01-04 4/A FORM 4/A SUBMISSION 0001209191-23-001351 4980
2022-12-28 4 FORM 4 SUBMISSION 0001209191-22-062858 4738
2022-12-15 4/A FORM 4/A SUBMISSION 0001209191-22-061485 7006
2022-12-15 4 FORM 4 SUBMISSION 0001209191-22-061483 6590
2022-12-14 4 FORM 4 SUBMISSION 0001209191-22-061328 6377
2022-12-09 4 FORM 4 SUBMISSION 0001209191-22-060582 4740
2022-12-09 4 FORM 4 SUBMISSION 0001209191-22-060581 4738
2022-12-09 4 FORM 4 SUBMISSION 0001209191-22-060580 5406
2022-12-02 4 FORM 4 SUBMISSION 0001209191-22-059472 4705
2022-11-07 10-Q 10-Q 0000950170-22-022605 001-36740 221365553 34 16003028 1 1
2022-11-07 8-K 8-K 2.02,9.01 0000950170-22-022593 001-36740 221365427 34 570108 1 1
2022-10-11 4 FORM 4 SUBMISSION 0001209191-22-053355 5379
2022-10-04 4 FORM 4 SUBMISSION 0001209191-22-052392 4713
2022-10-04 4 FORM 4 SUBMISSION 0001209191-22-052381 4705
2022-09-26 4 FORM 4 SUBMISSION 0001209191-22-051250 4711
2022-09-08 4 FORM 4 SUBMISSION 0001209191-22-049228 8818
2022-09-08 4 FORM 4 SUBMISSION 0001209191-22-049225 8825
2022-09-08 4 FORM 4 SUBMISSION 0001209191-22-049224 8821
2022-09-08 4 FORM 4 SUBMISSION 0001209191-22-049223 9493
2022-09-02 4 FORM 4 SUBMISSION 0001209191-22-048555 8814
2022-08-08 S-8 S-8 0001193125-22-215075 333-266667 221145534 33 83148
2022-08-08 S-3ASR S-3ASR 0001193125-22-215039 333-266663 221145376 33 976445
2022-08-08 10-Q 10-Q 0000950170-22-015530 001-36740 221144491 34 13419509 1 1
2022-08-08 8-K 8-K 2.02,9.01 0000950170-22-015516 001-36740 221144377 34 531161 1 1
2022-07-08 4 FORM 4 SUBMISSION 0001209191-22-041664 5548
2022-06-24 4 FORM 4 SUBMISSION 0001209191-22-039295 4880
2022-06-21 4 FORM 4 SUBMISSION 0001209191-22-038616 7160
2022-06-21 4 FORM 4 SUBMISSION 0001209191-22-038613 7150
2022-06-21 4 FORM 4 SUBMISSION 0001209191-22-038609 7129
2022-06-21 4 FORM 4 SUBMISSION 0001209191-22-038606 7168
2022-06-21 4 FORM 4 SUBMISSION 0001209191-22-038603 7167
2022-06-21 4 FORM 4 SUBMISSION 0001209191-22-038601 7162
2022-06-21 4 FORM 4 SUBMISSION 0001209191-22-038599 7843
2022-06-21 4 FORM 4 SUBMISSION 0001209191-22-038598 7850
2022-06-17 8-K 8-K 5.07 0000950170-22-011825 001-36740 221025105 34 164800 1 1
2022-06-08 4 FORM 4 SUBMISSION 0001209191-22-035220 4708
2022-06-08 4 FORM 4 SUBMISSION 0001209191-22-035219 5374
2022-06-08 4 FORM 4 SUBMISSION 0001209191-22-035217 4706
2022-06-08 8-K 8-K 5.02 0000950170-22-011324 001-36740 221003561 34 158716 1 1
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034041 4691
2022-05-09 10-Q 10-Q 0000950170-22-008573 001-36740 22906166 34 11887204 1 1
2022-05-09 8-K 8-K 2.02,9.01 0000950170-22-008488 001-36740 22904999 34 431970 1 1
2022-05-03 UPLOAD filename1.pdf 0000000000-22-004853 39602
2022-04-29 DEFA14A DEFA14A 0001564590-22-016542 001-36740 22869092 34 1705928
2022-04-29 DEF 14A DEF 14A 0001564590-22-016537 001-36740 22869070 34 4159682
2022-04-08 4 FORM 4 SUBMISSION 0001209191-22-023840 5370
2022-04-01 4 FORM 4 SUBMISSION 0001209191-22-022097 4704
2022-04-01 4 FORM 4 SUBMISSION 0001209191-22-022095 4696
2022-03-24 4 FORM 4 SUBMISSION 0001209191-22-021000 4702
2022-03-09 4 FORM 4 SUBMISSION 0001209191-22-017653 4703
2022-03-09 4 FORM 4 SUBMISSION 0001209191-22-017649 4704
2022-03-09 4 FORM 4 SUBMISSION 0001209191-22-017646 5370
2022-03-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-031864 005-88653 22724063 34 12879
2022-03-04 10-K/A 10-K/A 0001564590-22-008804 001-36740 22715116 34 20911562 1 1
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015366 4695
2022-02-28 10-K 10-K 0001564590-22-007632 001-36740 22690019 34 24548539 1 1
2022-02-28 8-K 8-K 2.02,9.01 0001564590-22-007611 001-36740 22689339 34 552935 1 1
2022-02-16 4 FORM 4 SUBMISSION 0001209191-22-010459 7233
2022-02-16 4 FORM 4 SUBMISSION 0001209191-22-010457 7230
2022-02-16 4 FORM 4 SUBMISSION 0001209191-22-010452 7229
2022-02-16 4 FORM 4 SUBMISSION 0001209191-22-010449 7234
2022-02-16 4 FORM 4 SUBMISSION 0001209191-22-010447 7904
2022-02-11 CORRESP filename1.htm 0001564590-22-004816 46331
2022-02-10 SC 13G SCHEDULE 13G 0000899140-22-000204 005-88653 22615197 34 57237
2022-02-10 SC 13G/A PRIMECAP MANAGEMENT CO/CA/ 0001085146-22-000725 005-88653 22612464 34 27297
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-017535 005-88653 22609739 34 12881
2022-02-02 UPLOAD filename1.pdf 0000000000-22-001355 45407
2022-02-01 SC 13G/A us31572q8087_020122.txt 0000834237-22-004511 005-88653 22579927 34 13290
2022-01-28 SC 13G SCHEDULE 13G 0001445546-22-000587 005-88653 22566973 34 16258
2022-01-20 CORRESP filename1.htm 0001564590-22-001799 64669
2022-01-07 4 FORM 4 SUBMISSION 0001209191-22-002496 5549
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001743 4695
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-001740 4704
2022-01-05 UPLOAD filename1.pdf 0000000000-22-000114 49052
2021-12-23 4 FORM 4 SUBMISSION 0001209191-21-071114 4881
2021-12-16 CORRESP filename1.htm 0001564590-21-060485 121226
2021-12-08 4 FORM 4 SUBMISSION 0001209191-21-068506 4705
2021-12-03 4 FORM 4 SUBMISSION 0001209191-21-067780 4697
2021-11-09 10-Q 10-Q 0001564590-21-055726 001-36740 211392274 34 16743492 1 1
2021-11-09 8-K 8-K 2.02,9.01 0001564590-21-055712 001-36740 211392088 34 544303 1 1
2021-11-08 UPLOAD filename1.pdf 0000000000-21-013517 58946
2021-10-08 4 FORM 4 SUBMISSION 0001209191-21-060056 5371
2021-10-06 4 FORM 4 SUBMISSION 0001209191-21-059871 7102
2021-10-06 4 FORM 4 SUBMISSION 0001209191-21-059869 7094
2021-09-24 4 FORM 4 SUBMISSION 0001209191-21-057566 4703
2021-09-17 4 FORM 4 SUBMISSION 0001209191-21-056604 6439
2021-09-09 4 FORM 4 SUBMISSION 0001209191-21-055405 4797
2021-09-09 4 FORM 4 SUBMISSION 0001209191-21-055403 4705
2021-09-09 4 FORM 4 SUBMISSION 0001209191-21-055402 7208
2021-09-09 3 FORM 3 SUBMISSION 0001209191-21-055400 7565
2021-08-30 4 FORM 4 SUBMISSION 0001209191-21-053980 4474
2021-08-27 8-K 8-K 5.02 0001564590-21-046125 001-36740 211219308 34 162886 1 1
2021-08-20 8-K 8-K 8.01,9.01 0001564590-21-045220 001-36740 211191418 34 249218 1 1
2021-08-16 8-K 8-K 5.02,9.01 0001564590-21-044718 001-36740 211179920 34 275059 1 1
2021-08-11 8-K 8-K 8.01,9.01 0001564590-21-043233 001-36740 211162081 34 274006 1 1
2021-08-10 SC 13G/A filing.txt 0000315066-21-001691 005-88653 211158813 34 8391
2021-08-09 S-8 S-8 0001193125-21-240673 333-258655 211157590 33 68895
2021-08-09 10-Q 10-Q 0001564590-21-042639 001-36740 211156620 34 18916907 1 1
2021-08-09 8-K 8-K 2.02,9.01 0001564590-21-042616 001-36740 211156438 34 528633 1 1
2021-07-20 8-K 8-K 1.01,9.01 0001564590-21-037222 001-36740 211101141 34 198610 1 1
2021-07-08 4 FORM 4 SUBMISSION 0001209191-21-046078 5546
2021-06-25 8-K 8-K 8.01,9.01 0001564590-21-034630 001-36740 211049097 34 431540 1 1
2021-06-24 4 FORM 4 SUBMISSION 0001209191-21-043157 4881
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041808 4676
2021-06-17 8-K 8-K 1.01,9.01 0001193125-21-193199 001-36740 211024955 34 183558 1 1
2021-06-09 4 FORM 4 SUBMISSION 0001209191-21-039294 4958
2021-06-09 4 FORM 4 SUBMISSION 0001209191-21-039293 4880
2021-06-07 8-K 8-K 1.01 0001564590-21-031969 001-36740 21999919 34 157413 1 1
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036684 7844
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036683 8082
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036682 7836
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036681 7162
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036679 8755
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036678 7154
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036677 7144
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036675 7123
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036671 7161
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036668 7160
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036666 7156
2021-05-27 8-K 8-K 5.07 0001564590-21-030428 001-36740 21972753 34 162936 1 1
2021-05-14 8-K 8-K 7.01 0001564590-21-028069 001-36740 21926132 34 158068 1 1
2021-05-10 10-Q 10-Q 0001564590-21-026053 001-36740 21907269 34 12670613 1 1
2021-05-10 8-K 8-K 2.02,9.01 0001564590-21-026046 001-36740 21907198 34 463172 1 1
2021-04-13 8-K 8-K 5.02 0001564590-21-018711 001-36740 21823319 34 164527 1 1
2021-04-13 DEFA14A DEFA14A 0001564590-21-018700 001-36740 21823240 34 131091
2021-04-13 DEF 14A DEF 14A 0001564590-21-018688 001-36740 21823160 34 3549762
2021-04-07 8-K 8-K 7.01,9.01 0001564590-21-017894 001-36740 21810789 34 275114 1 1
2021-04-06 8-K 8-K 8.01,9.01 0001564590-21-017841 001-36740 21809708 34 219033 1 1
2021-03-29 SEC STAFF LETTER filename1.pdf 9999999997-21-000978 276643
2021-03-15 4 FORM 4 SUBMISSION 0001209191-21-020548 11346
2021-03-10 4 FORM 4 SUBMISSION 0001209191-21-019555 4713
2021-03-10 4 FORM 4 SUBMISSION 0001209191-21-019551 4782
2021-03-10 4 FORM 4 SUBMISSION 0001209191-21-019549 4704
2021-03-01 10-K 10-K 0001564590-21-009871 001-36740 21698003 34 24969961 1 1
2021-03-01 8-K 8-K 2.02,9.01 0001564590-21-009846 001-36740 21697713 34 556177 1 1
2021-03-01 SEC STAFF LETTER filename1.pdf 9999999997-21-000616 277956
2021-02-26 4 FORM 4 SUBMISSION 0001209191-21-015013 7200
2021-02-26 4 FORM 4 SUBMISSION 0001209191-21-015010 7210

Latest XBRL company facts

One latest value per concept from companyfacts (414 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 4.05M 2026-10-13 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
dei EntityPublicFloat Entity Public Float USD 21.00M 2025-06-30 2025 FY 10-K 2026-03-16 0001193125-26-108346
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 968,344 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001193125-26-182044
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.15M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001193125-26-182044
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 2.19 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001193125-26-182044
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 4.58M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 4.58M 2023-06-30 2023 Q2 10-Q 2023-08-07 0000950170-23-039070
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 3.85M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap AccountsReceivableRelatedPartiesCurrent Accounts Receivable, Related Parties, Current USD 19.95M 2023-06-30 2023 Q2 10-Q 2023-08-07 0000950170-23-039070
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 309,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap AccrualForTaxesOtherThanIncomeTaxesCurrent Accrual for Taxes Other than Income Taxes, Current USD 7.12M 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125388
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 31.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 31.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 10.88M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.21M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.68B 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.19B 2018-06-30 2018 Q2 10-Q 2018-08-07 0001564590-18-019937
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 3.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 11,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009871
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 6.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 1.10M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 603,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap Assets Assets USD 48.85M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap AssetsCurrent Assets, Current USD 48.62M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 193.58M 2017-06-30 2017 Q2 10-Q 2017-08-07 0001564590-17-015989
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 87,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 30.47M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 354.51M 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055726
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 153,000 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055726
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 73,000 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055726
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 354.43M 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055726
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 407.49M 2019-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008161
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 30.39M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 28.09M 2018-06-30 2018 Q2 10-Q 2018-08-07 0001564590-18-019937
us-gaap AvailableForSaleSecuritiesEquitySecurities Available-for-sale Securities, Equity Securities USD 244,000 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009871
us-gaap AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments USD -8,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055726
us-gaap AvailableForSaleSecuritiesIncomeTaxExpenseOnChangeInUnrealizedHoldingGainOrLoss Available-for-sale Securities, Income Tax Expense on Change in Unrealized Holding Gain (Loss) (Deprecated 2018-01-31) USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003508
us-gaap AvailableForSaleSecuritiesNoncurrent Available-for-sale Securities, Noncurrent USD 10.59M 2018-06-30 2018 Q2 10-Q 2018-08-07 0001564590-18-019937
us-gaap BilledContractReceivables Billed Contracts Receivable USD 50.00M 2020-03-31 2019 Q3 10-Q 2020-11-05 0001564590-20-051315
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013728
us-gaap CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due USD 70.43M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008161
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 14.38M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008161
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFiveYears Capital Leases, Future Minimum Payments Due in Five Years USD 12.87M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008161
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFourYears Capital Leases, Future Minimum Payments Due in Four Years USD 14.34M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008161
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 14.18M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008161
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 14.66M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008161
us-gaap CapitalLeasesFutureMinimumPaymentsDueThereafter Capital Leases, Future Minimum Payments Due Thereafter USD 12.87M 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003508
us-gaap Cash Cash USD 1.89M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 9.90M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -14.65M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012411
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 9.90M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -37.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap CashDivestedFromDeconsolidation Cash Divested from Deconsolidation USD 5,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap CertificatesOfDepositAtCarryingValue Certificates of Deposit, at Carrying Value USD 8.47M 2015-09-30 2015 Q3 10-Q 2015-11-12 0001564590-15-010594
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 0 2021-12-31 2021 FY 10-K/A 2022-03-04 0001564590-22-008804
us-gaap CommercialPaperAtCarryingValue Commercial Paper, at Carrying Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2016-09-30 2016 Q3 10-Q 2016-11-08 0001564590-16-028331
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 81.12M 2015-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013728
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 225.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 4.05M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 4.05M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap CommonStockValue Common Stock, Value, Issued USD 41,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -2.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap ConstructionInProgressExpendituresIncurredButNotYetPaid Construction in Progress Expenditures Incurred but Not yet Paid USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap ContractualObligation Contractual Obligation USD 19.70M 2024-06-30 2024 Q2 10-Q 2024-08-06 0000950170-24-091808
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 58.91M 2021-12-31 2021 FY 10-K/A 2022-03-04 0001564590-22-008804
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 6.17M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 2.96M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 33.92M 2016-12-31 2016 FY 10-K 2017-03-01 0001564590-17-003095
us-gaap CostOfRevenue Cost of Revenue USD 4.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap CostsAndExpenses Costs and Expenses USD 48.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD -90,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD -90,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 74.10M 2023-05-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap DebtInstrumentFeeAmount Debt Instrument, Fee Amount USD 80.90M 2025-08-31 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 30.39M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 87,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment Debt Securities, Available-for-sale, Realized Gain (Loss), Excluding Other-than-temporary Impairment USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-06 0000950170-24-053554
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 30.39M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 87,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap DeconsolidationGainOrLossAmount Deconsolidation, Gain (Loss), Amount USD 30.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 900,000 2023-05-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 3.04M 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008161
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 16.93M 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012411
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 137.97M 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012411
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DeferredTaxAndOtherLiabilitiesNoncurrent Deferred Tax and Other Liabilities, Noncurrent USD 9.19M 2021-12-31 2021 FY 10-K/A 2022-03-04 0001564590-22-008804
us-gaap DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory USD 78.70M 2020-12-31 2022 FY 10-K 2023-02-27 0000950170-23-004668
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 387.56M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 10,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 173.19M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 112,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 6,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 128.92M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 2.13M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 4.76M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent USD 12,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 387.56M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DeferredTaxExpenseFromStockOptionsExercised Deferred Tax Expense from Stock Options Exercised USD 19.50M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001564590-17-003095
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 10,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 0 2021-12-31 2021 FY 10-K/A 2022-03-04 0001564590-22-008804
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 3.20M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009871
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.6 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009871
us-gaap Depreciation Depreciation USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 0 2021-12-31 2021 FY 10-K/A 2022-03-04 0001564590-22-008804
us-gaap DueFromRelatedPartiesNoncurrent Due from Related Parties, Noncurrent USD 1.48M 2020-09-30 2019 Q3 10-Q 2020-11-05 0001564590-20-051315
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 25.23M 2023-06-30 2023 Q2 10-Q 2023-08-07 0000950170-23-039070
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 577,000 2023-06-30 2023 Q2 10-Q 2023-08-07 0000950170-23-039070
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.76 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.68 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0000950170-22-008573
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.76 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 1.019 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount USD -90,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.014 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap EffectiveIncomeTaxRateReconciliationGiltiAmount EffectiveIncomeTaxRateReconciliationGiltiAmount USD 62.73M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure -1.076 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.096 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008161
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -68,000 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-12 0001193125-15-182983
us-gaap EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations USD -32,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012411
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -29,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.60M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap EquityMethodInvestments Equity Method Investments USD 5.81M 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125388
us-gaap EquityMethodInvestmentSoldCarryingAmount Equity Method Investment, Amount Sold CNY 7.30M 2020-01-01 2020-09-30 2019 Q3 10-Q 2020-11-05 0001564590-20-051315
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-09 0000950170-22-008573
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-09 0000950170-22-008573
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2021-12-31 2021 FY 10-K/A 2022-03-04 0001564590-22-008804
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2021-12-31 2021 FY 10-K/A 2022-03-04 0001564590-22-008804
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2021-01-01 2021-12-31 2021 FY 10-K/A 2022-03-04 0001564590-22-008804
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2021-01-01 2021-12-31 2021 FY 10-K/A 2022-03-04 0001564590-22-008804
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2024-07-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125388
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2024-07-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125388
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 1,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 6,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 144,000 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 34,000 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 70,000 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 162,000 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 0 2022-12-31 2022 FY 10-K 2023-02-27 0000950170-23-004668
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 47,000 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 0 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 37,000 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 39,000 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 39,000 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 6,000 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055726
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 18,000 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 5.85M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001564590-19-030812
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 97,000 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 20,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.063 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap ForeignCurrencyTransactionGainBeforeTax Foreign Currency Transaction Gain, before Tax USD 436,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-08 0001564590-16-028331
us-gaap ForeignCurrencyTransactionGainLossRealized Foreign Currency Transaction Gain (Loss), Realized USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009871
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -2.50M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD -66,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 1.70M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap GainsLossesOnRestructuringOfDebt Gains (Losses) on Restructuring of Debt USD 14.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 90.72M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-07 0000950170-22-022605
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap ImpairmentOfInvestments Other than Temporary Impairment Losses, Investments USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-06 0000950170-24-053554
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -47.92M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -58.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -10.38M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -3.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -3.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.74 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -0.74 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -66,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares -0.02 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares -0.02 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 2.66M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125388
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -59.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -12.24M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 9,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 5.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 271,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 578,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 836,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD -24.07M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 3.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap IncreaseDecreaseInAccountsReceivableRelatedParties Increase (Decrease) in Accounts Receivable, Related Parties USD -6.01M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 5.61M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004979
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 8.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 3.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -23.38M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -488,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -111,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -910,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap IncrementalCommonSharesAttributableToConversionOfPreferredStock Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock shares 0 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-13 0001193125-15-290007
us-gaap InterestAndOtherIncome Interest and Other Income USD 5.55M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009871
us-gaap InterestExpense Interest Expense USD 6.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap InterestExpenseDebt Interest Expense, Debt USD 3.00M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-12 0000950170-25-069203
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 41.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 7.83M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 8.40M 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-219374
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 5.21M 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125388
us-gaap InventoryNet Inventory, Net USD 3.25M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 0 2019-09-30 2019 Q3 10-Q 2020-11-05 0001564590-20-051315
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 3.15M 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 584,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028548
us-gaap LeaseCost Lease, Cost USD 8.63M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 90.35M 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 17.40M 2022-12-31 2022 FY 10-K 2023-02-27 0000950170-23-004668
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 17.55M 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 17.40M 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 18.48M 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 18.08M 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 18.84M 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 3.70M 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055726
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 9.73M 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap Liabilities Liabilities USD 56.04M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 48.85M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009871
us-gaap LiabilitiesCurrent Liabilities, Current USD 41.76M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 900,000 2021-06-30 2021 Q2 10-Q 2021-08-09 0001564590-21-042639
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012411
us-gaap LineOfCredit Long-term Line of Credit USD 1.70M 2024-09-27 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap LoansReceivableBasisSpreadOnVariableRate Loans Receivable, Basis Spread on Variable Rate pure 0.01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap LongTermDebt Long-term Debt USD 75.00M 2025-08-31 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap LongTermInvestments Long-term Investments USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 28.50M 2023-10-17 2026 Q1 10-Q 2026-05-12 0001193125-26-219374
us-gaap LossContingencyNewClaimsFiledNumber Loss Contingency, New Claims Filed, Number PutativeClassAction 5 2021-04-01 2021-05-31 2026 Q1 10-Q 2026-05-12 0001193125-26-219374
us-gaap LossContingencyReceivableCurrent Loss Contingency, Receivable, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 19.97M 2023-03-31 2023 Q1 10-Q 2023-05-08 0000950170-23-018814
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 8.01M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD 47.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -42.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 2.04M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012411
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 34.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 15.30M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012411
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -30.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -31.96M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012411
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -3.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 10.69M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-13 0001193125-15-290007
us-gaap NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD 175,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013728
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 2.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap NonredeemableNoncontrollingInterest Nonredeemable Noncontrolling Interest USD 520,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap OperatingExpenses Operating Expenses USD 267.06M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001564590-21-042639
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -44.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap OperatingLeaseCost Operating Lease, Cost USD 9.72M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.00M 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125388
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap OperatingLeasePayments Operating Lease, Payments USD 22.60M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 717,000 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008161
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 444,000 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008161
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 0 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008161
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 16,000 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008161
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 25,000 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008161
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 232,000 2018-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008161
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.42M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap OtherAssetsCurrent Other Assets, Current USD 514,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 231,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -124,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001564590-21-042639
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 396,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 272,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008161
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -124,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 60,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 3.01M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-12 0001564590-15-010594
us-gaap OtherSundryLiabilitiesNoncurrent Other Sundry Liabilities, Noncurrent USD 1.59M 2021-12-31 2021 FY 10-K/A 2022-03-04 0001564590-22-008804
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities Other than Temporary Impairment Losses, Investments, Available-for-sale Securities USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055726
us-gaap PaymentsForRestructuring Payments for Restructuring USD 3.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap PaymentsOfDebtRestructuringCosts Payments of Debt Restructuring Costs USD 42.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-02 0001564590-20-008161
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 17,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 397.91M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055726
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 18.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 2.15M 2020-01-01 2020-09-30 2019 Q3 10-Q 2020-11-05 0001564590-20-051315
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap PaymentsToMinorityShareholders Payments to Noncontrolling Interests USD 190,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 125.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2020-12-31 2021 FY 10-K/A 2022-03-04 0001564590-22-008804
us-gaap PremiumsAndOtherReceivablesNet Premiums and Other Receivables, Net USD 5.50M 2025-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.23M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 713,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013728
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 4.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap ProceedsFromDivestitureOfBusinessesNetOfCashDivested Proceeds from Divestiture of Businesses, Net of Cash Divested USD 96.61M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001564590-17-003095
us-gaap ProceedsFromIssuanceOfSecuredDebt Proceeds from Issuance of Secured Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013728
us-gaap ProceedsFromLongTermCapitalLeaseObligations Proceeds from Long-term Capital Lease Obligations USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009871
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 47.39M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028548
us-gaap ProceedsFromMinorityShareholders Proceeds from Noncontrolling Interests USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013728
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 50.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 4.00M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055726
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 721,000 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-12 0001193125-15-182983
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -3.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap ProvisionForOtherCreditLosses Provision for Other Credit Losses USD 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap RecordedUnconditionalPurchaseObligation Recorded Unconditional Purchase Obligation USD 2.77M 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap RecordedUnconditionalPurchaseObligationDueInSecondYear Recorded Unconditional Purchase Obligation, to be Paid, Year Two USD 636,000 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap RecordedUnconditionalPurchaseObligationDueWithinOneYear Recorded Unconditional Purchase Obligation, to be Paid, Year One USD 2.13M 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap RedeemableNoncontrollingInterestEquityCarryingAmount Redeemable Noncontrolling Interest, Equity, Carrying Amount USD 21.48M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap RepaymentsOfDebtAndCapitalLeaseObligations Repayments of Debt and Lease Obligation USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013728
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009871
us-gaap RepaymentsOfOtherLongTermDebt Repayments of Other Long-term Debt USD 403,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013728
us-gaap RepaymentsOfSecuredDebt Repayments of Secured Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap RepaymentsOfSeniorDebt Repayments of Senior Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 22.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 24.64M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-07 0000950170-23-039070
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings Restricted Stock, Shares Issued Net of Shares for Tax Withholdings shares 10,204 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.75 2024-07-01 2024-07-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap RestructuringCharges Restructuring Charges USD -48,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.71B 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 4.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap Revenues Revenues USD 6.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 131,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 55,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap SecuredDebtCurrent Secured Debt, Current USD 73.73M 2025-06-30 2025 Q2 10-Q 2025-08-11 0000950170-25-106549
us-gaap SecuredLongTermDebt Secured Long-term Debt, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 20.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 3.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 0 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013728
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 44.47 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 16,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 818,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 12,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 146,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 240.24 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 197,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 82,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 263,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 15.14 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 30,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 373,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 110.26 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 28,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 329,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 122.04 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 12.42 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0000950170-24-020161
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 577.45 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 59.65 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 15.14 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 18 2014-11-19 2016 FY 10-K 2017-03-01 0001564590-17-003095
us-gaap ShortTermInvestments Short-term Investments USD 30.39M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -29.19M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD -28.67M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap StockholdersEquityNoteSubscriptionsReceivable Stockholders' Equity Note, Subscriptions Receivable USD 0 2016-12-31 2016 FY 10-K 2017-03-01 0001564590-17-003095
us-gaap StockholdersEquityOther Stockholders' Equity, Other USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 520,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 9.31M 2014-11-18 2014-11-19 2016 FY 10-K 2017-03-01 0001564590-17-003095
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 168.44M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-01 0001564590-17-003095
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD -46,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 0 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004979
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 5.91M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001564590-17-003095
us-gaap SubleaseIncome Sublease Income USD 1.13M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap Supplies Prepaid Supplies USD 25.80M 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125388
us-gaap TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax Translation Adjustment Functional to Reporting Currency, Net of Tax USD 1.30M 2020-04-01 2021 FY 10-K/A 2022-03-04 0001564590-22-008804
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -1.10M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028548
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 74.50M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001564590-16-013728
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued Unrecognized Tax Benefits, Interest on Income Taxes Accrued USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040280
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 400,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap USGovernmentSecuritiesAtCarryingValue US Government Securities, at Carrying Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 65.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108346
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 4.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 93.04M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0000950170-22-008573
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 4.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-463519

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →